Quantum Biopharma (QNTM) Other Operating Expenses (2019 - 2026)

Quantum Biopharma has disclosed Other Operating Expenses across 8 years of filings, most recently posting $1.0 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $1.0 million, up 142.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 million (up 295.75% YoY), and the FY2025 annual result was $3.5 million, up 443.15% from the prior year.
• Other Operating Expenses came in at $1.0 million for Q1 2026 at Quantum Biopharma, up from $937823.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $4.8 million in Q1 2023 to a low of $177884.0 in Q1 2024.
• The 5-year median for Other Operating Expenses is $964395.0 (2025), against an average of $1.2 million.
• Across the five-year window, Other Operating Expenses plunged 96.31% in 2024 and soared 512.94% in 2025, its largest moves.
• Quantum Biopharma's Other Operating Expenses stood at $1.2 million in 2022, then soared by 176.86% to $3.3 million in 2023, then slumped by 94.57% to $177884.0 in 2024, then soared by 427.21% to $937823.0 in 2025, then climbed by 8.71% to $1.0 million in 2026.
• The last three Other Operating Expenses figures came in at $1.0 million (Q1 2026), $937823.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.